Pilot study demonstrates that long-term anti-IgE therapy improves symptoms and preserves hearing in eosinophilic otitis media, indicating middle ear inflammation control.
This pilot study provides new evidence establishing that long-term anti-IgE therapy improved the clinical ear symptoms of EOM and bone conduction hearing levels were mostly preserved. Therefore, long-term anti-IgE therapy can be effective for EOM to inhibit eosinophilic inflammation in the middle ear.
No takes yet. Share an insight, caveat, or question.
Iino et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: